Description

Spiro[Furan-3(2H),2(3H)-[1H]Pyrrolizine] (9Ci) is a complex spirocyclic organic compound featuring a fused furan and pyrrolizine ring system, serving as a valuable and versatile synthetic intermediate. Its unique three-dimensional, rigid structure makes it a critical building block for advanced pharmaceutical research and fine chemical synthesis. This compound is primarily sought by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and material science industries for constructing novel molecular architectures.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or requiring complex heterocyclic scaffolds.
• Agrochemical Research: Used in the development of new active ingredients for crop protection, leveraging its spirocyclic core for enhanced biological activity and stability.
• Material Science: Serves as a building block for organic electronic materials, such as those used in OLEDs or semiconductors, due to its potential charge-transport properties.
• Chemical Biology Probe Development: Utilized in creating specialized molecular probes and ligands for studying enzyme function and receptor interactions.
• Academic & Contract Research: Essential for methodological studies in organic synthesis, including novel cyclization and cross-coupling reactions.
• Fine Chemical Synthesis: Intermediate for producing specialty chemicals, flavors, and fragrances requiring complex, multi-ring structures.

Basic Information

Item	Details
Product Name	Spiro[Furan-3(2H),2(3H)-[1H]Pyrrolizine] (9Ci)
CAS No.	390412-97-2
Molecular Formula	C9H9NO
Molecular Weight	147.17 g/mol
Synonyms	Spiro[furan-3(2H),2'(3'H)-[1H]pyrrolizine]; 2,3-Dihydro-1H,3'H-spiro[furan-3,2'-pyrrolizine]; 390412-97-2; Spiro(furan-3(2H),2(3H)-[1H]pyrrolizine); 9CI Spiro[Furan-3(2H),2(3H)-[1H]Pyrrolizine]; Spirocyclic furan-pyrrolizine
EINECS	Contact for details

Quality Control

Our Spiro[Furan-3(2H),2(3H)-[1H]Pyrrolizine] (9Ci) is produced under strict quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and GC-MS, to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with every shipment, documenting all critical quality attributes. Our quality system is designed to support cGMP requirements for advanced pharmaceutical intermediates, ensuring traceability and reliability for your critical R&D and scale-up projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep the container sealed to prevent contamination and moisture absorption. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.